Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
PARIS and CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…
18,160€
0,39%
Echtzeit-Aktienkurs Nanobiotix S.A.
Bid:
Ask:
Nachrichten zur Nanobiotix S.A. Aktie
Soft Tissue Sarcoma Market Analysis Report 2025-2035, Profiles of Novartis, Nanobiotix, Adaptimmune, and Ipsen Pharma
The global soft tissue sarcoma market is poised for substantial growth from 2024 to 2035, driven by the rising prevalence…
NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
PARIS and CAMBRIDGE, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…
Nanobiotix S.A. überzeugt mit mehreren positiven Studienergebnissen — Aktie vor Ausbruch aus Base!
Nanobiotix S.A. ist ein spekulatives aber vielversprechenderes Biotechnologie-Unternehmen aus Frankreich. Es hat sich auf den Einsatz von Nanotechnologie bei Krebsbehandlungen…
Nanobiotix: Erste Erfolge im Kampf gegen therapieresistenten Krebs dank Nanotechnologie
Das französische Unternehmen weist bei seinem Kursverlauf spannende Parallelen zum gestern vorgestellten Medizintechnikspezialisten ClearPoint Neuro auf. Auch Nanobiotix befand sich…
Nanobiotix stock jumps on positive esophageal cancer treatment data By Investing.com
Nanobiotix stock jumps on positive esophageal cancer treatment data…
Nanobiotix: Todays Data Readout For Radiation Therapy Enhances Bull Case
…
Nanobiotix S.A. (NBTX) Q4 2024 Earnings Call Transcript
…
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
Conference call and webcast scheduled for Thursday, April 3, 2025, at 8:00 am EDT / 2:00 pm CEST Conference call…
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
PARIS and CAMBRIDGE, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…
NANOBIOTIX to Participate in Multiple Investor Conferences in November
~ Guggenheim’s Inaugural Healthcare Innovation Conference, Nov 11-13 ~…
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
PARIS and CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…
Nanobiotix S.A. (NBTX) Q1 2024 Earnings Call Transcript
…
Nanobiotix S.A. (NBTX) Q4 2023 Earnings Call Transcript
…
Nanobiotix to Present at Upcoming Investor Conferences in March
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…